173 related articles for article (PubMed ID: 15551325)
1. Altered expressions of HOX genes in human cutaneous malignant melanoma.
Maeda K; Hamada J; Takahashi Y; Tada M; Yamamoto Y; Sugihara T; Moriuchi T
Int J Cancer; 2005 Apr; 114(3):436-41. PubMed ID: 15551325
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA miR-196a controls melanoma-associated genes by regulating HOX-C8 expression.
Mueller DW; Bosserhoff AK
Int J Cancer; 2011 Sep; 129(5):1064-74. PubMed ID: 21077158
[TBL] [Abstract][Full Text] [Related]
3. Aberrant expression of HOX genes in human invasive breast carcinoma.
Makiyama K; Hamada J; Takada M; Murakawa K; Takahashi Y; Tada M; Tamoto E; Shindo G; Matsunaga A; Teramoto K; Komuro K; Kondo S; Katoh H; Koike T; Moriuchi T
Oncol Rep; 2005 Apr; 13(4):673-9. PubMed ID: 15756441
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of HOX genes in neoplastic and non-neoplastic human astrocytes.
Abdel-Fattah R; Xiao A; Bomgardner D; Pease CS; Lopes MB; Hussaini IM
J Pathol; 2006 May; 209(1):15-24. PubMed ID: 16463268
[TBL] [Abstract][Full Text] [Related]
5. Altered HOX gene expression in human skin and breast cancer cells.
Svingen T; Tonissen KF
Cancer Biol Ther; 2003; 2(5):518-23. PubMed ID: 14614318
[TBL] [Abstract][Full Text] [Related]
6. PAX4 has the potential to function as a tumor suppressor in human melanoma.
Hata S; Hamada J; Maeda K; Murai T; Tada M; Furukawa H; Tsutsumida A; Saito A; Yamamoto Y; Moriuchi T
Int J Oncol; 2008 Nov; 33(5):1065-71. PubMed ID: 18949370
[TBL] [Abstract][Full Text] [Related]
7. Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi.
Sand M; Skrygan M; Sand D; Georgas D; Gambichler T; Hahn SA; Altmeyer P; Bechara FG
Cell Tissue Res; 2013 Jan; 351(1):85-98. PubMed ID: 23111773
[TBL] [Abstract][Full Text] [Related]
8. The miRNA machinery in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases and benign melanocytic nevi.
Sand M; Skrygan M; Georgas D; Sand D; Gambichler T; Altmeyer P; Bechara FG
Cell Tissue Res; 2012 Oct; 350(1):119-26. PubMed ID: 22706980
[TBL] [Abstract][Full Text] [Related]
9. Aberrant expression of HOX genes in oral dysplasia and squamous cell carcinoma tissues.
Hassan NM; Hamada J; Murai T; Seino A; Takahashi Y; Tada M; Zhang X; Kashiwazaki H; Yamazaki Y; Inoue N; Moriuchi T
Oncol Res; 2006; 16(5):217-24. PubMed ID: 17294802
[TBL] [Abstract][Full Text] [Related]
10. Disordered expression of HOX genes in human non-small cell lung cancer.
Abe M; Hamada J; Takahashi O; Takahashi Y; Tada M; Miyamoto M; Morikawa T; Kondo S; Moriuchi T
Oncol Rep; 2006 Apr; 15(4):797-802. PubMed ID: 16525661
[TBL] [Abstract][Full Text] [Related]
11. Increased HOX C13 expression in metastatic melanoma progression.
Cantile M; Scognamiglio G; Anniciello A; Farina M; Gentilcore G; Santonastaso C; Fulciniti F; Cillo C; Franco R; Ascierto PA; Botti G
J Transl Med; 2012 May; 10():91. PubMed ID: 22583695
[TBL] [Abstract][Full Text] [Related]
12. Differential patterns of HOX gene expression are associated with specific integrin and ICAM profiles in clonal populations isolated from a single human melanoma metastasis.
Cillo C; Cantile M; Mortarini R; Barba P; Parmiani G; Anichini A
Int J Cancer; 1996 May; 66(5):692-7. PubMed ID: 8647634
[TBL] [Abstract][Full Text] [Related]
13. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
[TBL] [Abstract][Full Text] [Related]
14. Aberrant expressions of HOX genes in colorectal and hepatocellular carcinomas.
Kanai M; Hamada J; Takada M; Asano T; Murakawa K; Takahashi Y; Murai T; Tada M; Miyamoto M; Kondo S; Moriuchi T
Oncol Rep; 2010 Mar; 23(3):843-51. PubMed ID: 20127028
[TBL] [Abstract][Full Text] [Related]
15. Quantitative HOX expression in chromosomally defined subsets of acute myelogenous leukemia.
Drabkin HA; Parsy C; Ferguson K; Guilhot F; Lacotte L; Roy L; Zeng C; Baron A; Hunger SP; Varella-Garcia M; Gemmill R; Brizard F; Brizard A; Roche J
Leukemia; 2002 Feb; 16(2):186-95. PubMed ID: 11840284
[TBL] [Abstract][Full Text] [Related]
16. Dysregulated expression of HOX and ParaHOX genes in human esophageal squamous cell carcinoma.
Takahashi O; Hamada J; Abe M; Hata S; Asano T; Takahashi Y; Tada M; Miyamoto M; Kondo S; Moriuchi T
Oncol Rep; 2007 Apr; 17(4):753-60. PubMed ID: 17342311
[TBL] [Abstract][Full Text] [Related]
17. HOX genes in human lung: altered expression in primary pulmonary hypertension and emphysema.
Golpon HA; Geraci MW; Moore MD; Miller HL; Miller GJ; Tuder RM; Voelkel NF
Am J Pathol; 2001 Mar; 158(3):955-66. PubMed ID: 11238043
[TBL] [Abstract][Full Text] [Related]
18. Aberrant expression of posterior HOX genes in well differentiated histotypes of thyroid cancers.
Cantile M; Scognamiglio G; La Sala L; La Mantia E; Scaramuzza V; Valentino E; Tatangelo F; Losito S; Pezzullo L; Chiofalo MG; Fulciniti F; Franco R; Botti G
Int J Mol Sci; 2013 Nov; 14(11):21727-40. PubMed ID: 24189220
[TBL] [Abstract][Full Text] [Related]
19. Quantitative expression of the homeobox and integrin genes in human gastric carcinoma.
Rossi Degl'Innocenti D; Castiglione F; Buccoliero AM; Bechi P; Taddei GL; Freschi G; Taddei A
Int J Mol Med; 2007 Oct; 20(4):621-9. PubMed ID: 17786296
[TBL] [Abstract][Full Text] [Related]
20. Differential Hox expression in murine embryonic stem cell models of normal and malignant hematopoiesis.
Wheadon H; Ramsey JM; Dobbin E; Dickson GJ; Corrigan PM; Freeburn RW; Thompson A
Stem Cells Dev; 2011 Aug; 20(8):1465-76. PubMed ID: 21083428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
